The Efficacy and Safety of Pyrotinib, Trastuzumab Combined With Taxanes in the Treatment of Trastuzumab-treated HER2+ Advanced Breast Cancer (ABC).
Clinical trial NCT06217185 · RECRUITING
Trial details
- NCT number
- NCT06217185
- Sponsor
- Hebei Medical University Fourth Hospital
- Status
- RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2024-01-02
- Primary completion
- 2025-12-11
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.